je.st
news
Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech
2014-12-01 14:52:54| Biotech - Topix.net
The CEO who sold Idenix Pharmaceuticals to Merck & Co. in August for $3.9 billion, the area's largest biotech acquisition this year, has a new job.
Tags: sale
head
ceo
cambridge
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||